We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: No jubilee euphoria as inflation fears remain

Wed, 01st Jun 2022 17:06

(Alliance News) - Stocks in London ended lower on Wednesday ahead of the extra long Jubilee bank holiday weekend as investors weigh inflation and interest rates.

The FTSE 100 index closed down 74.71 points, or 1.0%, at 7,532.95. The mid-cap FTSE 250 index closed down 145.05 points, or 0.7%, at 20,272.90. The AIM All-Share index closed down 3.14 points, or 0.3%, at 972.60.

The Cboe UK 100 index closed down 0.9% at 749.82. The Cboe 250 ended down 0.6% at 17,967.78 and the Cboe Small Companies finished 0.3% higher at 14,657.51.

In mainland Europe, the CAC 40 stock index in Paris closed down 0.8%, while the DAX 40 in Frankfurt ended down 0.3%.

"UK markets have been in no mood for celebrations today, running out of steam after last week's rebound and suggesting that we are in for more losses as June gets underway. It looks like investors remain much more cautious about chasing gain in equities, and if anything remain firmly averse to recommitting themselves to stocks as the outlook for growth and inflation continues to worsen," said IG Group's Chris Beauchamp.

In the FTSE 100, GSK closed down 1.6%. The drugmaker said it has submitted to the UK Financial Conduct Authority its plan for the demerger of its consumer healthcare arm and its listing in London and New York as Haleon.

The separation will take the form of a demerger of at least 80% of GSK's current 68% share of the consumer business to GSK shareholders. The remaining 32% of Consumer Healthcare currently is held by US peer Pfizer.

Pfizer was down 2.0% in New York.

Following the float, GSK shareholders will own 54.5% of Haleon, while GSK's UK pension schemes will have 7.5%. GSK itself will retain up to 6%, but GSK said Pfizer intends to sell off its 32% stake in Haleon "in a disciplined manner, with the objective of maximising value for Pfizer shareholders".

Haleon will be listed as ordinary shares in London and as American depositary shares on the New York Stock Exchange.

In the FTSE 250, Dr Martens ended the star performer, up 20%, after the iconic bootmaker posted annual earnings ahead of market expectations.

For the financial year that ended March 31, pretax profit surged to GBP214.3 million from GBP69.7 million the year prior. Revenue rose to GBP908.3 million from GBP773.0 million.

Dr Martens declared an annual dividend of 5.5 pence, compared to none the year before.

Capricorn Energy ended up 1.9% after it agreed to an all-share merger with fellow FTSE 250 energy firm Tullow Oil.

Tullow closed down 2.0%.

Under the deal terms, Capricorn shareholders will receive 3.8068 new Tullow shares for each Tullow share, giving Capricorn shareholders 47% of the enlarged firm.

Tullow Oil has a market cap of about GBP769 million, while Capricorn - formerly known as Cairn Energy - has a market cap of about GBP644 million.

"The boards of Tullow and Capricorn believe the combination has compelling strategic, operational and financial rationale, with the ability to deliver substantial benefits to shareholders, host nations and other stakeholders," Tullow said in the statement.

"The combination represents a unique opportunity to create a leading African energy company, listed in London, with the financial flexibility and human resource capability to access and accelerate near-term organic growth, add new reserves and resources cost-effectively, generate significant future returns for shareholders, and pursue further consolidation".

The pair guided for pre-financing free cash flows of USD2.4 billion from 2022 to 2025 following the merger.

The pound was quoted at USD1.2490 at the London equities close, down sharply from USD1.2605 at the close Tuesday.

Sterling found little support after the manufacturing sector in the UK saw growth slow in May, with a hit to demand leading to a seven-month low in output.

The seasonally adjusted S&P Global-CIPS UK manufacturing purchasing managers' index posted 54.6 points in May, unchanged from the earlier flash estimate and down from 55.8 in April.

The reading was in line with market forecasts, cited by FXStreet. S&P noted the sector was hit by falling output, new orders and employment.

The euro stood at USD1.0655 at the European equities close, down from USD1.0722 late Tuesday.

On the continent, a reading on the health of the eurozone manufacturing sector fell to its lowest reading for 18 months in May, final survey data revealed.

The S&P Global eurozone manufacturing purchasing managers' index fell to 54.6 points in May from 55.5 in April, signalling a weaker improvement in the health of the euro area's manufacturing sector.

However, for Germany, the PMI score saw a slight improvement from the 20-month low registered in April.

The headline seasonally adjusted PMI inched up to 54.8 points in May from 54.6 the month prior. The survey indicated a sustained softening of demand for German manufactured goods, with a combination of heightened economic uncertainty and sharply rising prices. In addition, Covid-related lockdowns in China led to a further decline in new orders.

Against the yen, the dollar was trading at JPY129.95, up sharply from JPY128.50 late Tuesday.

Stocks in New York were lower at the London equities close as worries about an aggressive tightening to rein on decades-high inflation and the economic slowdown continued to grip Wall Street

The DJIA was down 0.5%, the S&P 500 index down 0.6% and the Nasdaq Composite down 0.1%.

On Wall Street, Dow member Salesforce rocketed 13% higher after the software provider reported better-than-expected earnings and said consumer demand was robust.

Brent oil was quoted at USD117.23 a barrel at the equities close, sinking from USD123.75 at the close Tuesday.

Oil prices remained under pressure after the Wall Street Journal Tuesday reported that some OPEC members are exploring the idea of suspending Russia's participation in an oil-production deal as Western sanctions and a partial European ban begin to undercut Moscow's ability to pump more.

Meanwhile, ministers from OPEC+, which groups the Organization of the Petroleum Exporting Countries, Russia and others, meet on Thursday to discuss oil output policy and are expected to confirm a previously agreed increase in oil production.

Gold stood at USD1,843.12 an ounce at the London equities close, slightly lower against USD1,845.51 late Tuesday.

The economic events calendar on Thursday has eurozone producer prices at 1000 BST and the latest US jobless claims numbers at 1330 BST. Financial markets in the UK will be closed on Thursday for the Spring Bank Holiday and on Friday for the Platinum Jubilee.

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.